Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
Don Deyo, Executive Chair at Reach Neuro, Inc., shared on LinkedIn about a recent article by Roberto M. de Freitas et al, published in Nature Medicine, adding:
”I am excited to share that the clinical research underlying Reach Neuro‘s breakthrough therapy for post-stroke upper limb impairment has been published in Nature Medicine.
For stroke survivors, the loss of arm and hand function can have a profound impact on independence and quality of life.
This study demonstrates that targeted spinal cord stimulation can significantly improve arm strength, mobility, and dexterity, even years after a stroke.
This publication represents an important milestone in the journey to bring a transformative therapy to the millions of people living with chronic stroke-related disability.
It is a testament to the vision, dedication, and scientific excellence of the researchers, clinicians, engineers, and study participants who made this work possible.
As Executive Chairman of Reach Neuro, I am honored to work alongside such an exceptional team as we advance this technology toward broader clinical application.
My congratulations and gratitude go to Dr. Marco Capogrosso, Dr. Peter Gerszten, Dr. Douglas Weber, Dr. Elvira Pirondini, their collaborators, and the study participants whose commitment made this achievement possible.
Read more about the publication and its significance.”
Title: Spinal cord stimulation for upper limb motor function in people with chronic post-stroke hemiparesis: a feasibility trial
Authors: Roberto M. de Freitas, Shovan Bhatia, Erynn Sorensen, Nikhil Verma, Erick Carranza, Scott Ensel, Luigi Borda, Amy Boos, Jeff Goldsmith, Lee E. Fisher, Daryl P. Fields, Marc P. Powell, Shane Gordon, Jeffrey Balzer, Robert M. Friedlander, George F. Wittenberg, Peter C. Gerszten, John W. Krakauer, Elvira Pirondini, Douglas J. Weber, Marco Capogrosso
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 23:43Shadi Tabibian: The Clinical Power of Patient Stories in Rare Bleeding Disorders
-
Jul 21, 2026, 23:35Pete Stibbs: Impressed with PE Compass and Clinical Compass from Mona Ranade and Team
-
Jul 21, 2026, 23:28Toby Richards: Important Announcement about Testing for Iron Deficiency
-
Jul 21, 2026, 21:12Ammar Al Awawdeh: Bridging the Hemostatic Gap – Functional Platelet Salvage in CPB
-
Jul 21, 2026, 19:44Shinya Goto: JCS/JPCPHS 2025 Guideline Now Available in English
-
Jul 21, 2026, 19:43Abdul Mannan: Why Is HbS or HbD Approximately 40% in Heterozygotes Rather Than 50%?
-
Jul 21, 2026, 19:42Haemophilia Maintains a 2025 Impact Factor of 3.0 – WFH
-
Jul 21, 2026, 19:41Wolfgang Miesbach: SR604 Restores Thrombin Generation Where It Is Needed
-
Jul 21, 2026, 19:40Filmon Tesfay: Our New Case Report on Cerebral Venous Thrombosis Is Now Published